Longwood Fund Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 85

  • Portfolio
  • 27

  • Exits
  • 32

Exits

Longwood Fund Management General Information

Company Description

Founded in 2010, Longwood Fund is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in the healthcare, pharmaceutical, and biotechnology sectors. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Corporate Office
  • The Prudential Tower, 800 Boylston Street
  • Suite 1715
  • Boston, MA 02199
  • United States
+1 (617)

Longwood Fund Management Investments (85)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Khartis Therapeutics 13-Aug-2026 Early Stage VC Drug Discovery Startup
Crystalys Therapeutics 22-Jul-2026 Drug Discovery Clinical Trials - Phase 3
Avenzo Therapeutics 01-Jun-2026 Drug Discovery Clinical Trials - Phase 1
Coultreon Biopharma 28-Apr-2026 Drug Discovery Generating Revenue
Sidewinder Therapeutics 25-Mar-2026 Drug Discovery Generating Revenue
Neomorph 17-Mar-2026 Drug Discovery Clinical Trials - General
Mediar Therapeutics 10-Dec-2025 Drug Discovery Clinical Trials - Phase 1
AAVantgarde Bio 03-Nov-2025 Drug Discovery Clinical Trials - Phase 2
Crystalys Therapeutics 30-Sep-2025 Early Stage VC Drug Discovery Clinical Trials - Phase 3
Avenzo Therapeutics 22-Aug-2025 Early Stage VC Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 85 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longwood Fund Management Exits (32)

Company Name Exit Date Exit Type Exit Size
Be Biopharma 05-Oct-2026 Out of Business
Pyxis Oncology 01-Oct-2026
Immunitas Therapeutics 12-May-2026
Colorescience 02-Feb-2026
Doppler Bio 07-Jan-2026
Evommune 06-Nov-2025
Tome Biosciences 03-Nov-2025
Interius BioTherapeutics 14-Oct-2025
BridgeBio Oncology Therapeutics 11-Aug-2025 Reverse Merger
ImmuneID 22-Nov-2024 Out of Business
You’re viewing 10 of 32 exits. Get the full list »

Longwood Fund Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Longwood Fund Management FAQs

  • What is Longwood Fund Management?

    Founded in 2010, Longwood Fund is a venture capital firm based in Boston, Massachusetts.

  • When was Longwood Fund Management founded?

    Longwood Fund Management was founded in 2010.

  • Where is Longwood Fund Management headquartered?

    Longwood Fund Management is headquartered in Boston, MA.

  • What is Longwood Fund Management's total asset value?

    Longwood Fund Management has around in total assets under management.

  • How many investments has Longwood Fund Management made?

    Longwood Fund Management has made 85 investments.

  • What has Longwood Fund Management invested in?

    Longwood Fund Management has made numerous investments in companies like Khartis Therapeutics, Crystalys Therapeutics, and Avenzo Therapeutics within the Drug Discovery industry.

  • What has Longwood Fund Management invested in recently?

    Longwood Fund Management's latest investment was on 13-Aug-2026 in Khartis Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process